Helena W. Rodbard
-
- Diabetes Treatment and Management 63
- Diabetes Management and Research 55
- Diabetes, Cardiovascular Risks, and Lipoproteins 5
- Pharmacology top 1%
- Pharmacology and Obesity Treatment 10
- Surgery top 2%
- Pancreatic function and diabetes 21
- Reproductive Medicine top 2%
- Molecular Biology top 5%
- Metabolism, Diabetes, and Cancer 31
-
- Diabetes and associated disorders 7
-
- Health Systems, Economic Evaluations, Quality of Life 6
- Co-authors
- Yehuda HandelsmanPaul S. JellingerJohn B. BuseDonald A. BergmanJohn A. SeibelHarold BaysAlan J. GarberJ. Michael González-Campoy
- Journals
- JAMA (1 paper)SHILAP Revista de lepidopterología (1 paper)The Journal of Clinical Endocrinology & Metabolism (3 papers)
- Partner nations
- United StatesDenmarkUnited Kingdom
In The Last Decade
Helena W. Rodbard
98 papers receiving 5.5k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Endocrinology, Diabetes and Metabolism 4.4k
- Pharmacology 612
- Surgery 1.5k
- Reproductive Medicine 274
- Molecular Biology 1.8k
Countries citing papers authored by Helena W. Rodbard
This map shows the geographic impact of Helena W. Rodbard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helena W. Rodbard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helena W. Rodbard more than expected).
Fields of papers citing papers by Helena W. Rodbard
This network shows the impact of papers produced by Helena W. Rodbard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helena W. Rodbard. The network helps show where Helena W. Rodbard may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Helena W. Rodbard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2023 | 3 | |
| 3 | 2023 | 5 | |
| 4 | Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetesbreakdown → | 2023 | 82 |
| 5 | 2023 | 75 | |
| 6 | 2022 | 4 | |
| 7 | 2021 | 2 | |
| 8 | 2020 | 2 | |
| 9 | 2020 | 3 | |
| 10 | 2019 | 21 | |
| 11 | 2019 | 47 | |
| 12 | 2018 | 3 | |
| 13 | 2013 | 39 | |
| 14 | 2013 | 53 | |
| 15 | Reduced nocturnal hypoglycaemia with insulin degludec as compared to insulin glargine: results of a 2-year randomised trial in type 2 diabetes | 2012 | 2 |
| 16 | 2010 | 67 | |
| 17 | 2010 | 29 | |
| 18 | 2008 | 33 | |
| 19 | 2007 | 29 | |
| 20 | 2007 | 18 |
About Helena W. Rodbard
Helena W. Rodbard is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacy and Pharmacology, having authored 100 papers that have together received 5.9k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (63 papers), Diabetes Management and Research (55 papers), Metabolism, Diabetes, and Cancer (31 papers), Pancreatic function and diabetes (21 papers), Pharmacology and Obesity Treatment (10 papers), Diabetes and associated disorders (7 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.4k citations), Pharmacology (612 citations) and Surgery (1.5k citations). Helena W. Rodbard has collaborated with scholars based in United States, Denmark and United Kingdom. Frequent co-authors include Yehuda Handelsman, Paul S. Jellinger, John B. Buse, Donald A. Bergman, John A. Seibel, Harold Bays, Alan J. Garber, J. Michael González-Campoy, Alan B. Schorr and Bertrand Cariou. Their work appears in journals such as JAMA, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.